This was a case-case study among 121 patients defined as high risk ( tumor size > 5 cm and/or nodal involvement ; n = 59 ) or low risk ( 5 cm , node negative ; n = 62 ) within the mitomycin-C arm of the Radiation Therapy Oncology Group 98-11 trial .